Conatus Pharmaceuticals Appoints Kathy Scott as Independent Board Member

Date : 11/18/2019 @ 9:05PM
Source : GlobeNewswire Inc.
Stock : Conatus Pharmaceuticals Inc (CNAT)
Quote : 0.3951  0.0101 (2.62%) @ 1:00AM
Conatus Pharmaceuticals share price Chart

Conatus Pharmaceuticals Appoints Kathy Scott as Independent Board Member

Conatus Pharmaceuticals (NASDAQ:CNAT)
Historical Stock Chart

6 Months : From Aug 2019 to Feb 2020

Click Here for more Conatus Pharmaceuticals Charts.

Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) today announced the appointment of Kathleen D. Scott to the Conatus Board of Directors as an additional independent member.

“We are pleased to expand the perspective of our Board of Directors with the addition of a proven financial leader with substantial experience in strategic transactions, corporate governance and financial reporting,” said Steven J. Mento, Ph.D., President, Chief Executive Officer and co-founder of Conatus. “Kathy’s demonstrated capabilities across a broad range of life science finance initiatives should prove most helpful to Conatus as we continue with Oppenheimer & Co., Inc., in our review of strategic alternatives.”

Kathleen ScottMs. Scott is currently a Managing Director at Hale BioPharma Ventures, and Chief Financial Officer for some of its portfolio companies in the life science industry including Adigica Health, an e-commerce company focused on selling health care products direct to the consumer; Recros Medica, a development stage company designing a medical device to be used by plastic surgeons and dermatologists for skin tightening; and Neurana Pharmaceuticals, a specialty pharmaceutical company developing therapeutic products to treat unmet needs in diseases and conditions of the central nervous system. Ms. Scott also was previously the Chief Financial Officer of Oncternal Therapeutics, Clarify Medical and MDRejuvena.

Ms. Scott has over 25 years of experience in finance, accounting, M&A, and restructurings for public and private companies. Previously Ms. Scott was a Partner at RA Capital Advisors, a San Diego private investment bank providing financial advisory services. She spent over 15 years with RA Capital Advisors, completing billions of dollars of mergers, acquisitions, divestitures, and restructurings for a broad range of corporate clients. Ms. Scott started her career as an auditor in Arthur Andersen’s San Diego office, focusing on both public and private clients. Ms. Scott is a CPA and CFA charter holder. She is currently chair of the board of directors of the YMCA of San Diego County and a board member of Corporate Directors’ Forum.

CONTACT: Keith MarshallConatus Pharmaceuticals Inc.(858) 376-2600IR@conatuspharma.com

Latest CNAT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200229 05:12:51